Legislation to Advance Equality and Inclusion in Oncology Clinical Trials
According to the Association for Clinical Oncology, individuals who identify as African American or Black make up 13.4% of the
According to the Association for Clinical Oncology, individuals who identify as African American or Black make up 13.4% of the
In clinical research, working with organizations that understand the ins and outs of the phase of your trial is key
It’s safe to say 2020 has been more unpredictable than anyone could imagine. Through these unprecedented times, we have worked to provide the
FDA has recently issued guidance relating to changes for Certificates of Confidentiality (CoCs) brought about by the 21st Century Cures
Community-based participatory research (CBPR) continues to come up in conversations surrounding diversity and inclusion in clinical research. This specialized method
The United States regulations governing research with humans pay special attention to two ethical concepts that may not be familiar
In our latest webinar, a panel of experts from research organizations, Community Health Centers (CHCs) and healthcare tech discussed racial
As part of FDA’s response to combat COVID-19, FDA convened its Vaccines and Related Biological Products Advisory Committee (VRBPAC). The
We are honored to support a resilient research community during the COVID-19 pandemic. See the data points in our infographic to find out how Advarra helps keep research moving forward.
While many clinical trials are initiated by industry sponsors, such as pharmaceutical companies or contract research organizations (CROs), other trials
Racial Diversity in Clinical Trials: Building Trust in Participant Engagement While racial and ethnic diversity in clinical trial participation has
Drawing on the perspectives of experts from Parexel and Advarra, this white paper explores the evolving role of technology in clinical research and its impact on research sites and study conduct.